Chia‐Yen Dai

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang et al. · Hepatology · 2008 · 278 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

Shigeki Nakagawa, Lan Wei, Won Min Song et al. · Cancer Cell · 2016 · 210 citations · Full text

Medicine, Molecular Medicine, Oncology +16

OxLDL up‐regulates microRNA‐29b, leading to epigenetic modifications of <i>MMP‐2/MMP‐9</i> genes: a novel mechanism for cardiovascular diseases

Ku‐Chung Chen, Yung‐Song Wang, Ching-Yu Hu et al. · The FASEB Journal · 2011 · 207 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan

Ming‐Lung Yu, Shi‐Ming Lin, Wan‐Long Chuang et al. · Antiviral Therapy · 2006 · 183 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Ming‐Lung Yu, Chung‐Feng Huang, Jee‐Fu Huang et al. · Hepatology · 2010 · 179 citations · Full text

Medicine, Infectious Diseases, Molecular Genetics +17